Insider Transactions in Q2 2023 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2023
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
509
-0.15%
|
$8,144
$16.29 P/Share
|
|
Apr 25
2023
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,633
-0.79%
|
$42,128
$16.29 P/Share
|
|
Apr 18
2023
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,423
-0.96%
|
$51,345
$15.27 P/Share
|
|
Apr 18
2023
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,544
-0.36%
|
$23,160
$15.27 P/Share
|
|
Apr 18
2023
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,395
-0.27%
|
$50,925
$15.27 P/Share
|
|
Apr 17
2023
|
Jay S Stout Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 12
2023
|
Douglas J. Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,523
+9.92%
|
-
|
|
Apr 12
2023
|
Atul Pande Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,523
+11.59%
|
-
|
|
Apr 12
2023
|
George V Migausky Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,523
+9.27%
|
-
|
|
Apr 12
2023
|
Andrew J. Fromkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,523
+11.03%
|
-
|
|
Apr 12
2023
|
Julia G. Butchko Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,188
+18.84%
|
-
|
|
Apr 12
2023
|
Frank Torti Director |
BUY
Grant, award, or other acquisition
|
Direct |
121,916
+19.13%
|
-
|
|
Apr 12
2023
|
William L. Macias Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,664
+20.0%
|
-
|
|
Apr 12
2023
|
Eva Renee Barnett Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,664
+19.76%
|
-
|
|
Apr 12
2023
|
Mark S. Levine Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,664
+20.82%
|
-
|
|
Apr 12
2023
|
Peter Salzmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
243,832
+16.46%
|
-
|